Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

Mise à jour : Il y a 4 ans
Référence : NCT02279966

Femme et Homme

Extrait

To assess the efficacy of acute treatment with 10 mg/day vortioxetine versus placebo on cognitive performance (focusing on the aspect concerning speed of processing, executive functioning, attention) in working patients with major depressive disorder (MDD).


Critère d'inclusion

  • Major Depressive Disorder


Liens